nodes	percent_of_prediction	percent_of_DWPC	metapath
Metoprolol—CYP2C19—epilepsy syndrome	0.153	0.44	CbGaD
Metoprolol—CYP2D6—epilepsy syndrome	0.113	0.327	CbGaD
Metoprolol—ABCB1—epilepsy syndrome	0.0809	0.233	CbGaD
Metoprolol—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0289	0.0736	CbGbCtD
Metoprolol—CYP2C19—Felbamate—epilepsy syndrome	0.0269	0.0685	CbGbCtD
Metoprolol—CYP2C19—Trimethadione—epilepsy syndrome	0.0269	0.0685	CbGbCtD
Metoprolol—ABCB1—Levetiracetam—epilepsy syndrome	0.0255	0.065	CbGbCtD
Metoprolol—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0253	0.0644	CbGbCtD
Metoprolol—CYP2C19—Clobazam—epilepsy syndrome	0.0219	0.0558	CbGbCtD
Metoprolol—CYP2C19—Carbamazepine—epilepsy syndrome	0.0182	0.0462	CbGbCtD
Metoprolol—ABCB1—Clobazam—epilepsy syndrome	0.0177	0.045	CbGbCtD
Metoprolol—ABCB1—Lamotrigine—epilepsy syndrome	0.017	0.0433	CbGbCtD
Metoprolol—CYP2C19—Primidone—epilepsy syndrome	0.017	0.0432	CbGbCtD
Metoprolol—CYP2C19—Phenytoin—epilepsy syndrome	0.0163	0.0415	CbGbCtD
Metoprolol—CYP2C19—Propofol—epilepsy syndrome	0.0152	0.0387	CbGbCtD
Metoprolol—ABCB1—Carbamazepine—epilepsy syndrome	0.0147	0.0373	CbGbCtD
Metoprolol—CYP2C19—Phenobarbital—epilepsy syndrome	0.0145	0.037	CbGbCtD
Metoprolol—CYP2C19—Diazepam—epilepsy syndrome	0.0138	0.035	CbGbCtD
Metoprolol—CYP2C19—Zonisamide—epilepsy syndrome	0.0134	0.0342	CbGbCtD
Metoprolol—ABCB1—Phenytoin—epilepsy syndrome	0.0131	0.0335	CbGbCtD
Metoprolol—ABCB1—Phenobarbital—epilepsy syndrome	0.0117	0.0298	CbGbCtD
Metoprolol—ABCB1—Midazolam—epilepsy syndrome	0.0116	0.0294	CbGbCtD
Metoprolol—CYP2D6—Propofol—epilepsy syndrome	0.0116	0.0294	CbGbCtD
Metoprolol—ABCB1—Diazepam—epilepsy syndrome	0.0111	0.0283	CbGbCtD
Metoprolol—CYP2C19—Valproic Acid—epilepsy syndrome	0.0109	0.0276	CbGbCtD
Metoprolol—CYP2C19—Topiramate—epilepsy syndrome	0.00979	0.0249	CbGbCtD
Metoprolol—Chlorphenesin—BCHE—epilepsy syndrome	0.000334	0.172	CrCbGaD
Metoprolol—Betaxolol—CYP2D6—epilepsy syndrome	0.000185	0.095	CrCbGaD
Metoprolol—Bisoprolol—CYP2D6—epilepsy syndrome	0.000178	0.0917	CrCbGaD
Metoprolol—Acebutolol—CYP2D6—epilepsy syndrome	0.000169	0.0869	CrCbGaD
Metoprolol—Oxprenolol—CYP2D6—epilepsy syndrome	0.000168	0.0863	CrCbGaD
Metoprolol—Chlorphenesin—PTGS2—epilepsy syndrome	0.000154	0.0791	CrCbGaD
Metoprolol—Alprenolol—CYP2D6—epilepsy syndrome	0.000153	0.0789	CrCbGaD
Metoprolol—Pindolol—CYP2D6—epilepsy syndrome	0.000132	0.0679	CrCbGaD
Metoprolol—Atenolol—ABCB1—epilepsy syndrome	0.000131	0.0672	CrCbGaD
Metoprolol—Acebutolol—ABCB1—epilepsy syndrome	0.000121	0.062	CrCbGaD
Metoprolol—Propranolol—CYP2C19—epilepsy syndrome	9.71e-05	0.0499	CrCbGaD
Metoprolol—Propranolol—CYP2D6—epilepsy syndrome	7.2e-05	0.037	CrCbGaD
Metoprolol—Propranolol—ABCB1—epilepsy syndrome	5.14e-05	0.0264	CrCbGaD
Metoprolol—Nausea—Midazolam—epilepsy syndrome	5.01e-05	0.000257	CcSEcCtD
Metoprolol—Hallucination—Topiramate—epilepsy syndrome	5.01e-05	0.000257	CcSEcCtD
Metoprolol—Muscle spasms—Gabapentin—epilepsy syndrome	5e-05	0.000257	CcSEcCtD
Metoprolol—Tachycardia—Valproic Acid—epilepsy syndrome	5e-05	0.000257	CcSEcCtD
Metoprolol—Diarrhoea—Zonisamide—epilepsy syndrome	5e-05	0.000257	CcSEcCtD
Metoprolol—Loss of consciousness—Pregabalin—epilepsy syndrome	4.99e-05	0.000256	CcSEcCtD
Metoprolol—Asthenia—Oxcarbazepine—epilepsy syndrome	4.99e-05	0.000256	CcSEcCtD
Metoprolol—Pruritus—Clonazepam—epilepsy syndrome	4.98e-05	0.000256	CcSEcCtD
Metoprolol—Vomiting—Vigabatrin—epilepsy syndrome	4.98e-05	0.000256	CcSEcCtD
Metoprolol—Skin disorder—Valproic Acid—epilepsy syndrome	4.98e-05	0.000256	CcSEcCtD
Metoprolol—Oedema peripheral—Topiramate—epilepsy syndrome	4.96e-05	0.000254	CcSEcCtD
Metoprolol—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.95e-05	0.000254	CcSEcCtD
Metoprolol—Pruritus—Phenytoin—epilepsy syndrome	4.95e-05	0.000254	CcSEcCtD
Metoprolol—Connective tissue disorder—Topiramate—epilepsy syndrome	4.94e-05	0.000254	CcSEcCtD
Metoprolol—Nausea—Levetiracetam—epilepsy syndrome	4.94e-05	0.000254	CcSEcCtD
Metoprolol—Rash—Vigabatrin—epilepsy syndrome	4.94e-05	0.000253	CcSEcCtD
Metoprolol—Dizziness—Felbamate—epilepsy syndrome	4.93e-05	0.000253	CcSEcCtD
Metoprolol—Dermatitis—Vigabatrin—epilepsy syndrome	4.93e-05	0.000253	CcSEcCtD
Metoprolol—Pruritus—Oxcarbazepine—epilepsy syndrome	4.92e-05	0.000253	CcSEcCtD
Metoprolol—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.92e-05	0.000252	CcSEcCtD
Metoprolol—Vision blurred—Gabapentin—epilepsy syndrome	4.91e-05	0.000252	CcSEcCtD
Metoprolol—Headache—Vigabatrin—epilepsy syndrome	4.9e-05	0.000252	CcSEcCtD
Metoprolol—Hypertension—Pregabalin—epilepsy syndrome	4.9e-05	0.000252	CcSEcCtD
Metoprolol—Vomiting—Diazepam—epilepsy syndrome	4.9e-05	0.000252	CcSEcCtD
Metoprolol—Rash—Diazepam—epilepsy syndrome	4.86e-05	0.00025	CcSEcCtD
Metoprolol—Dermatitis—Diazepam—epilepsy syndrome	4.86e-05	0.000249	CcSEcCtD
Metoprolol—Visual impairment—Topiramate—epilepsy syndrome	4.85e-05	0.000249	CcSEcCtD
Metoprolol—Chest pain—Pregabalin—epilepsy syndrome	4.83e-05	0.000248	CcSEcCtD
Metoprolol—Arthralgia—Pregabalin—epilepsy syndrome	4.83e-05	0.000248	CcSEcCtD
Metoprolol—Dizziness—Zonisamide—epilepsy syndrome	4.83e-05	0.000248	CcSEcCtD
Metoprolol—Headache—Diazepam—epilepsy syndrome	4.83e-05	0.000248	CcSEcCtD
Metoprolol—Anxiety—Pregabalin—epilepsy syndrome	4.82e-05	0.000247	CcSEcCtD
Metoprolol—Diarrhoea—Clonazepam—epilepsy syndrome	4.81e-05	0.000247	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	4.8e-05	0.000246	CcSEcCtD
Metoprolol—Hypotension—Valproic Acid—epilepsy syndrome	4.79e-05	0.000246	CcSEcCtD
Metoprolol—Asthenia—Carbamazepine—epilepsy syndrome	4.79e-05	0.000246	CcSEcCtD
Metoprolol—Diarrhoea—Phenytoin—epilepsy syndrome	4.78e-05	0.000246	CcSEcCtD
Metoprolol—Nausea—Fosphenytoin—epilepsy syndrome	4.77e-05	0.000245	CcSEcCtD
Metoprolol—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.76e-05	0.000244	CcSEcCtD
Metoprolol—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.75e-05	0.000244	CcSEcCtD
Metoprolol—Vomiting—Felbamate—epilepsy syndrome	4.74e-05	0.000244	CcSEcCtD
Metoprolol—Dry mouth—Pregabalin—epilepsy syndrome	4.73e-05	0.000243	CcSEcCtD
Metoprolol—Pruritus—Carbamazepine—epilepsy syndrome	4.72e-05	0.000242	CcSEcCtD
Metoprolol—Rash—Felbamate—epilepsy syndrome	4.7e-05	0.000242	CcSEcCtD
Metoprolol—Eye disorder—Topiramate—epilepsy syndrome	4.7e-05	0.000241	CcSEcCtD
Metoprolol—Dermatitis—Felbamate—epilepsy syndrome	4.7e-05	0.000241	CcSEcCtD
Metoprolol—Tinnitus—Topiramate—epilepsy syndrome	4.69e-05	0.000241	CcSEcCtD
Metoprolol—Vertigo—Gabapentin—epilepsy syndrome	4.68e-05	0.00024	CcSEcCtD
Metoprolol—Headache—Felbamate—epilepsy syndrome	4.67e-05	0.00024	CcSEcCtD
Metoprolol—Confusional state—Pregabalin—epilepsy syndrome	4.67e-05	0.00024	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.67e-05	0.00024	CcSEcCtD
Metoprolol—Cardiac disorder—Topiramate—epilepsy syndrome	4.67e-05	0.00024	CcSEcCtD
Metoprolol—Syncope—Gabapentin—epilepsy syndrome	4.67e-05	0.00024	CcSEcCtD
Metoprolol—Leukopenia—Gabapentin—epilepsy syndrome	4.66e-05	0.000239	CcSEcCtD
Metoprolol—Dizziness—Clonazepam—epilepsy syndrome	4.65e-05	0.000239	CcSEcCtD
Metoprolol—Nausea—Vigabatrin—epilepsy syndrome	4.65e-05	0.000239	CcSEcCtD
Metoprolol—Vomiting—Zonisamide—epilepsy syndrome	4.64e-05	0.000238	CcSEcCtD
Metoprolol—Insomnia—Valproic Acid—epilepsy syndrome	4.63e-05	0.000238	CcSEcCtD
Metoprolol—Oedema—Pregabalin—epilepsy syndrome	4.63e-05	0.000238	CcSEcCtD
Metoprolol—Asthenia—Lamotrigine—epilepsy syndrome	4.63e-05	0.000238	CcSEcCtD
Metoprolol—Dizziness—Phenytoin—epilepsy syndrome	4.62e-05	0.000237	CcSEcCtD
Metoprolol—Rash—Zonisamide—epilepsy syndrome	4.6e-05	0.000236	CcSEcCtD
Metoprolol—Paraesthesia—Valproic Acid—epilepsy syndrome	4.6e-05	0.000236	CcSEcCtD
Metoprolol—Palpitations—Gabapentin—epilepsy syndrome	4.6e-05	0.000236	CcSEcCtD
Metoprolol—Dermatitis—Zonisamide—epilepsy syndrome	4.6e-05	0.000236	CcSEcCtD
Metoprolol—Dizziness—Oxcarbazepine—epilepsy syndrome	4.6e-05	0.000236	CcSEcCtD
Metoprolol—Nausea—Diazepam—epilepsy syndrome	4.58e-05	0.000235	CcSEcCtD
Metoprolol—Loss of consciousness—Gabapentin—epilepsy syndrome	4.57e-05	0.000235	CcSEcCtD
Metoprolol—Headache—Zonisamide—epilepsy syndrome	4.57e-05	0.000235	CcSEcCtD
Metoprolol—Dyspnoea—Valproic Acid—epilepsy syndrome	4.57e-05	0.000235	CcSEcCtD
Metoprolol—Diarrhoea—Carbamazepine—epilepsy syndrome	4.57e-05	0.000234	CcSEcCtD
Metoprolol—Angiopathy—Topiramate—epilepsy syndrome	4.56e-05	0.000234	CcSEcCtD
Metoprolol—Pruritus—Lamotrigine—epilepsy syndrome	4.56e-05	0.000234	CcSEcCtD
Metoprolol—Shock—Pregabalin—epilepsy syndrome	4.56e-05	0.000234	CcSEcCtD
Metoprolol—Somnolence—Valproic Acid—epilepsy syndrome	4.56e-05	0.000234	CcSEcCtD
Metoprolol—Immune system disorder—Topiramate—epilepsy syndrome	4.54e-05	0.000233	CcSEcCtD
Metoprolol—Nervous system disorder—Pregabalin—epilepsy syndrome	4.54e-05	0.000233	CcSEcCtD
Metoprolol—Thrombocytopenia—Pregabalin—epilepsy syndrome	4.54e-05	0.000233	CcSEcCtD
Metoprolol—Mediastinal disorder—Topiramate—epilepsy syndrome	4.53e-05	0.000233	CcSEcCtD
Metoprolol—Tachycardia—Pregabalin—epilepsy syndrome	4.52e-05	0.000232	CcSEcCtD
Metoprolol—Dyspepsia—Valproic Acid—epilepsy syndrome	4.51e-05	0.000232	CcSEcCtD
Metoprolol—Skin disorder—Pregabalin—epilepsy syndrome	4.5e-05	0.000231	CcSEcCtD
Metoprolol—Hypertension—Gabapentin—epilepsy syndrome	4.49e-05	0.000231	CcSEcCtD
Metoprolol—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.48e-05	0.00023	CcSEcCtD
Metoprolol—Vomiting—Clonazepam—epilepsy syndrome	4.47e-05	0.00023	CcSEcCtD
Metoprolol—Alopecia—Topiramate—epilepsy syndrome	4.45e-05	0.000228	CcSEcCtD
Metoprolol—Vomiting—Phenytoin—epilepsy syndrome	4.44e-05	0.000228	CcSEcCtD
Metoprolol—Rash—Clonazepam—epilepsy syndrome	4.44e-05	0.000228	CcSEcCtD
Metoprolol—Dermatitis—Clonazepam—epilepsy syndrome	4.43e-05	0.000228	CcSEcCtD
Metoprolol—Chest pain—Gabapentin—epilepsy syndrome	4.43e-05	0.000228	CcSEcCtD
Metoprolol—Arthralgia—Gabapentin—epilepsy syndrome	4.43e-05	0.000228	CcSEcCtD
Metoprolol—Nausea—Felbamate—epilepsy syndrome	4.43e-05	0.000228	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.42e-05	0.000227	CcSEcCtD
Metoprolol—Vomiting—Oxcarbazepine—epilepsy syndrome	4.42e-05	0.000227	CcSEcCtD
Metoprolol—Fatigue—Valproic Acid—epilepsy syndrome	4.42e-05	0.000227	CcSEcCtD
Metoprolol—Anxiety—Gabapentin—epilepsy syndrome	4.42e-05	0.000227	CcSEcCtD
Metoprolol—Dizziness—Carbamazepine—epilepsy syndrome	4.41e-05	0.000227	CcSEcCtD
Metoprolol—Diarrhoea—Lamotrigine—epilepsy syndrome	4.41e-05	0.000227	CcSEcCtD
Metoprolol—Headache—Clonazepam—epilepsy syndrome	4.41e-05	0.000226	CcSEcCtD
Metoprolol—Rash—Phenytoin—epilepsy syndrome	4.41e-05	0.000226	CcSEcCtD
Metoprolol—Mental disorder—Topiramate—epilepsy syndrome	4.41e-05	0.000226	CcSEcCtD
Metoprolol—Dermatitis—Phenytoin—epilepsy syndrome	4.4e-05	0.000226	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.4e-05	0.000226	CcSEcCtD
Metoprolol—Rash—Oxcarbazepine—epilepsy syndrome	4.38e-05	0.000225	CcSEcCtD
Metoprolol—Constipation—Valproic Acid—epilepsy syndrome	4.38e-05	0.000225	CcSEcCtD
Metoprolol—Pain—Valproic Acid—epilepsy syndrome	4.38e-05	0.000225	CcSEcCtD
Metoprolol—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.38e-05	0.000225	CcSEcCtD
Metoprolol—Headache—Phenytoin—epilepsy syndrome	4.38e-05	0.000225	CcSEcCtD
Metoprolol—Headache—Oxcarbazepine—epilepsy syndrome	4.36e-05	0.000224	CcSEcCtD
Metoprolol—Nausea—Zonisamide—epilepsy syndrome	4.34e-05	0.000223	CcSEcCtD
Metoprolol—Dry mouth—Gabapentin—epilepsy syndrome	4.33e-05	0.000223	CcSEcCtD
Metoprolol—Hypotension—Pregabalin—epilepsy syndrome	4.33e-05	0.000222	CcSEcCtD
Metoprolol—Flatulence—Topiramate—epilepsy syndrome	4.32e-05	0.000222	CcSEcCtD
Metoprolol—Tension—Topiramate—epilepsy syndrome	4.3e-05	0.000221	CcSEcCtD
Metoprolol—Dysgeusia—Topiramate—epilepsy syndrome	4.29e-05	0.00022	CcSEcCtD
Metoprolol—Confusional state—Gabapentin—epilepsy syndrome	4.28e-05	0.00022	CcSEcCtD
Metoprolol—Dizziness—Lamotrigine—epilepsy syndrome	4.26e-05	0.000219	CcSEcCtD
Metoprolol—Nervousness—Topiramate—epilepsy syndrome	4.25e-05	0.000218	CcSEcCtD
Metoprolol—Oedema—Gabapentin—epilepsy syndrome	4.25e-05	0.000218	CcSEcCtD
Metoprolol—Vomiting—Carbamazepine—epilepsy syndrome	4.24e-05	0.000218	CcSEcCtD
Metoprolol—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.22e-05	0.000217	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.22e-05	0.000217	CcSEcCtD
Metoprolol—Muscle spasms—Topiramate—epilepsy syndrome	4.21e-05	0.000216	CcSEcCtD
Metoprolol—Rash—Carbamazepine—epilepsy syndrome	4.21e-05	0.000216	CcSEcCtD
Metoprolol—Dermatitis—Carbamazepine—epilepsy syndrome	4.2e-05	0.000216	CcSEcCtD
Metoprolol—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	4.19e-05	0.000215	CcSEcCtD
Metoprolol—Insomnia—Pregabalin—epilepsy syndrome	4.19e-05	0.000215	CcSEcCtD
Metoprolol—Nausea—Clonazepam—epilepsy syndrome	4.18e-05	0.000215	CcSEcCtD
Metoprolol—Headache—Carbamazepine—epilepsy syndrome	4.18e-05	0.000215	CcSEcCtD
Metoprolol—Shock—Gabapentin—epilepsy syndrome	4.18e-05	0.000215	CcSEcCtD
Metoprolol—Nervous system disorder—Gabapentin—epilepsy syndrome	4.17e-05	0.000214	CcSEcCtD
Metoprolol—Paraesthesia—Pregabalin—epilepsy syndrome	4.16e-05	0.000214	CcSEcCtD
Metoprolol—Thrombocytopenia—Gabapentin—epilepsy syndrome	4.16e-05	0.000214	CcSEcCtD
Metoprolol—Nausea—Phenytoin—epilepsy syndrome	4.15e-05	0.000213	CcSEcCtD
Metoprolol—Tachycardia—Gabapentin—epilepsy syndrome	4.15e-05	0.000213	CcSEcCtD
Metoprolol—Dyspnoea—Pregabalin—epilepsy syndrome	4.13e-05	0.000212	CcSEcCtD
Metoprolol—Nausea—Oxcarbazepine—epilepsy syndrome	4.13e-05	0.000212	CcSEcCtD
Metoprolol—Vision blurred—Topiramate—epilepsy syndrome	4.13e-05	0.000212	CcSEcCtD
Metoprolol—Skin disorder—Gabapentin—epilepsy syndrome	4.13e-05	0.000212	CcSEcCtD
Metoprolol—Somnolence—Pregabalin—epilepsy syndrome	4.12e-05	0.000211	CcSEcCtD
Metoprolol—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.11e-05	0.000211	CcSEcCtD
Metoprolol—Vomiting—Lamotrigine—epilepsy syndrome	4.1e-05	0.000211	CcSEcCtD
Metoprolol—Urticaria—Valproic Acid—epilepsy syndrome	4.07e-05	0.000209	CcSEcCtD
Metoprolol—Rash—Lamotrigine—epilepsy syndrome	4.07e-05	0.000209	CcSEcCtD
Metoprolol—Dermatitis—Lamotrigine—epilepsy syndrome	4.06e-05	0.000209	CcSEcCtD
Metoprolol—Body temperature increased—Valproic Acid—epilepsy syndrome	4.05e-05	0.000208	CcSEcCtD
Metoprolol—Abdominal pain—Valproic Acid—epilepsy syndrome	4.05e-05	0.000208	CcSEcCtD
Metoprolol—Headache—Lamotrigine—epilepsy syndrome	4.04e-05	0.000207	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4e-05	0.000205	CcSEcCtD
Metoprolol—Fatigue—Pregabalin—epilepsy syndrome	3.99e-05	0.000205	CcSEcCtD
Metoprolol—Hypotension—Gabapentin—epilepsy syndrome	3.97e-05	0.000204	CcSEcCtD
Metoprolol—Nausea—Carbamazepine—epilepsy syndrome	3.96e-05	0.000204	CcSEcCtD
Metoprolol—Constipation—Pregabalin—epilepsy syndrome	3.96e-05	0.000203	CcSEcCtD
Metoprolol—Pain—Pregabalin—epilepsy syndrome	3.96e-05	0.000203	CcSEcCtD
Metoprolol—Vertigo—Topiramate—epilepsy syndrome	3.93e-05	0.000202	CcSEcCtD
Metoprolol—Syncope—Topiramate—epilepsy syndrome	3.93e-05	0.000202	CcSEcCtD
Metoprolol—Leukopenia—Topiramate—epilepsy syndrome	3.92e-05	0.000201	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.87e-05	0.000199	CcSEcCtD
Metoprolol—Palpitations—Topiramate—epilepsy syndrome	3.87e-05	0.000199	CcSEcCtD
Metoprolol—Loss of consciousness—Topiramate—epilepsy syndrome	3.85e-05	0.000198	CcSEcCtD
Metoprolol—Insomnia—Gabapentin—epilepsy syndrome	3.84e-05	0.000197	CcSEcCtD
Metoprolol—Nausea—Lamotrigine—epilepsy syndrome	3.83e-05	0.000197	CcSEcCtD
Metoprolol—Feeling abnormal—Pregabalin—epilepsy syndrome	3.82e-05	0.000196	CcSEcCtD
Metoprolol—Paraesthesia—Gabapentin—epilepsy syndrome	3.81e-05	0.000196	CcSEcCtD
Metoprolol—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.79e-05	0.000195	CcSEcCtD
Metoprolol—Dyspnoea—Gabapentin—epilepsy syndrome	3.79e-05	0.000194	CcSEcCtD
Metoprolol—Hypertension—Topiramate—epilepsy syndrome	3.78e-05	0.000194	CcSEcCtD
Metoprolol—Somnolence—Gabapentin—epilepsy syndrome	3.78e-05	0.000194	CcSEcCtD
Metoprolol—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.78e-05	0.000194	CcSEcCtD
Metoprolol—Dyspepsia—Gabapentin—epilepsy syndrome	3.74e-05	0.000192	CcSEcCtD
Metoprolol—Chest pain—Topiramate—epilepsy syndrome	3.73e-05	0.000191	CcSEcCtD
Metoprolol—Arthralgia—Topiramate—epilepsy syndrome	3.73e-05	0.000191	CcSEcCtD
Metoprolol—Anxiety—Topiramate—epilepsy syndrome	3.72e-05	0.000191	CcSEcCtD
Metoprolol—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.7e-05	0.00019	CcSEcCtD
Metoprolol—Urticaria—Pregabalin—epilepsy syndrome	3.68e-05	0.000189	CcSEcCtD
Metoprolol—Asthenia—Valproic Acid—epilepsy syndrome	3.68e-05	0.000189	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.67e-05	0.000188	CcSEcCtD
Metoprolol—Fatigue—Gabapentin—epilepsy syndrome	3.66e-05	0.000188	CcSEcCtD
Metoprolol—Body temperature increased—Pregabalin—epilepsy syndrome	3.66e-05	0.000188	CcSEcCtD
Metoprolol—Abdominal pain—Pregabalin—epilepsy syndrome	3.66e-05	0.000188	CcSEcCtD
Metoprolol—Dry mouth—Topiramate—epilepsy syndrome	3.65e-05	0.000187	CcSEcCtD
Metoprolol—Pain—Gabapentin—epilepsy syndrome	3.63e-05	0.000187	CcSEcCtD
Metoprolol—Constipation—Gabapentin—epilepsy syndrome	3.63e-05	0.000187	CcSEcCtD
Metoprolol—Pruritus—Valproic Acid—epilepsy syndrome	3.63e-05	0.000186	CcSEcCtD
Metoprolol—Confusional state—Topiramate—epilepsy syndrome	3.6e-05	0.000185	CcSEcCtD
Metoprolol—Oedema—Topiramate—epilepsy syndrome	3.57e-05	0.000184	CcSEcCtD
Metoprolol—Shock—Topiramate—epilepsy syndrome	3.52e-05	0.000181	CcSEcCtD
Metoprolol—Diarrhoea—Valproic Acid—epilepsy syndrome	3.51e-05	0.00018	CcSEcCtD
Metoprolol—Nervous system disorder—Topiramate—epilepsy syndrome	3.5e-05	0.00018	CcSEcCtD
Metoprolol—Feeling abnormal—Gabapentin—epilepsy syndrome	3.5e-05	0.00018	CcSEcCtD
Metoprolol—Thrombocytopenia—Topiramate—epilepsy syndrome	3.5e-05	0.00018	CcSEcCtD
Metoprolol—Tachycardia—Topiramate—epilepsy syndrome	3.49e-05	0.000179	CcSEcCtD
Metoprolol—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.47e-05	0.000178	CcSEcCtD
Metoprolol—Skin disorder—Topiramate—epilepsy syndrome	3.47e-05	0.000178	CcSEcCtD
Metoprolol—Hyperhidrosis—Topiramate—epilepsy syndrome	3.45e-05	0.000177	CcSEcCtD
Metoprolol—Hypersensitivity—Pregabalin—epilepsy syndrome	3.41e-05	0.000175	CcSEcCtD
Metoprolol—Dizziness—Valproic Acid—epilepsy syndrome	3.39e-05	0.000174	CcSEcCtD
Metoprolol—Urticaria—Gabapentin—epilepsy syndrome	3.37e-05	0.000173	CcSEcCtD
Metoprolol—Abdominal pain—Gabapentin—epilepsy syndrome	3.36e-05	0.000172	CcSEcCtD
Metoprolol—Body temperature increased—Gabapentin—epilepsy syndrome	3.36e-05	0.000172	CcSEcCtD
Metoprolol—Hypotension—Topiramate—epilepsy syndrome	3.34e-05	0.000171	CcSEcCtD
Metoprolol—Asthenia—Pregabalin—epilepsy syndrome	3.32e-05	0.000171	CcSEcCtD
Metoprolol—Pruritus—Pregabalin—epilepsy syndrome	3.28e-05	0.000168	CcSEcCtD
Metoprolol—Vomiting—Valproic Acid—epilepsy syndrome	3.26e-05	0.000167	CcSEcCtD
Metoprolol—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.26e-05	0.000167	CcSEcCtD
Metoprolol—Insomnia—Topiramate—epilepsy syndrome	3.23e-05	0.000166	CcSEcCtD
Metoprolol—Rash—Valproic Acid—epilepsy syndrome	3.23e-05	0.000166	CcSEcCtD
Metoprolol—Dermatitis—Valproic Acid—epilepsy syndrome	3.23e-05	0.000166	CcSEcCtD
Metoprolol—Headache—Valproic Acid—epilepsy syndrome	3.21e-05	0.000165	CcSEcCtD
Metoprolol—Paraesthesia—Topiramate—epilepsy syndrome	3.21e-05	0.000165	CcSEcCtD
Metoprolol—Dyspnoea—Topiramate—epilepsy syndrome	3.19e-05	0.000164	CcSEcCtD
Metoprolol—Somnolence—Topiramate—epilepsy syndrome	3.18e-05	0.000163	CcSEcCtD
Metoprolol—Diarrhoea—Pregabalin—epilepsy syndrome	3.17e-05	0.000163	CcSEcCtD
Metoprolol—Dyspepsia—Topiramate—epilepsy syndrome	3.15e-05	0.000162	CcSEcCtD
Metoprolol—Hypersensitivity—Gabapentin—epilepsy syndrome	3.13e-05	0.000161	CcSEcCtD
Metoprolol—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.09e-05	0.000158	CcSEcCtD
Metoprolol—Fatigue—Topiramate—epilepsy syndrome	3.08e-05	0.000158	CcSEcCtD
Metoprolol—Dizziness—Pregabalin—epilepsy syndrome	3.06e-05	0.000157	CcSEcCtD
Metoprolol—Constipation—Topiramate—epilepsy syndrome	3.06e-05	0.000157	CcSEcCtD
Metoprolol—Pain—Topiramate—epilepsy syndrome	3.06e-05	0.000157	CcSEcCtD
Metoprolol—Asthenia—Gabapentin—epilepsy syndrome	3.05e-05	0.000157	CcSEcCtD
Metoprolol—Nausea—Valproic Acid—epilepsy syndrome	3.04e-05	0.000156	CcSEcCtD
Metoprolol—Pruritus—Gabapentin—epilepsy syndrome	3.01e-05	0.000154	CcSEcCtD
Metoprolol—Vomiting—Pregabalin—epilepsy syndrome	2.95e-05	0.000151	CcSEcCtD
Metoprolol—Feeling abnormal—Topiramate—epilepsy syndrome	2.95e-05	0.000151	CcSEcCtD
Metoprolol—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.92e-05	0.00015	CcSEcCtD
Metoprolol—Rash—Pregabalin—epilepsy syndrome	2.92e-05	0.00015	CcSEcCtD
Metoprolol—Dermatitis—Pregabalin—epilepsy syndrome	2.92e-05	0.00015	CcSEcCtD
Metoprolol—Diarrhoea—Gabapentin—epilepsy syndrome	2.91e-05	0.000149	CcSEcCtD
Metoprolol—Headache—Pregabalin—epilepsy syndrome	2.9e-05	0.000149	CcSEcCtD
Metoprolol—Urticaria—Topiramate—epilepsy syndrome	2.84e-05	0.000146	CcSEcCtD
Metoprolol—Body temperature increased—Topiramate—epilepsy syndrome	2.83e-05	0.000145	CcSEcCtD
Metoprolol—Abdominal pain—Topiramate—epilepsy syndrome	2.83e-05	0.000145	CcSEcCtD
Metoprolol—Dizziness—Gabapentin—epilepsy syndrome	2.81e-05	0.000144	CcSEcCtD
Metoprolol—Nausea—Pregabalin—epilepsy syndrome	2.75e-05	0.000141	CcSEcCtD
Metoprolol—Vomiting—Gabapentin—epilepsy syndrome	2.7e-05	0.000139	CcSEcCtD
Metoprolol—Rash—Gabapentin—epilepsy syndrome	2.68e-05	0.000138	CcSEcCtD
Metoprolol—Dermatitis—Gabapentin—epilepsy syndrome	2.68e-05	0.000137	CcSEcCtD
Metoprolol—Headache—Gabapentin—epilepsy syndrome	2.66e-05	0.000137	CcSEcCtD
Metoprolol—Hypersensitivity—Topiramate—epilepsy syndrome	2.63e-05	0.000135	CcSEcCtD
Metoprolol—Asthenia—Topiramate—epilepsy syndrome	2.56e-05	0.000132	CcSEcCtD
Metoprolol—Pruritus—Topiramate—epilepsy syndrome	2.53e-05	0.00013	CcSEcCtD
Metoprolol—Nausea—Gabapentin—epilepsy syndrome	2.52e-05	0.00013	CcSEcCtD
Metoprolol—Diarrhoea—Topiramate—epilepsy syndrome	2.45e-05	0.000126	CcSEcCtD
Metoprolol—Dizziness—Topiramate—epilepsy syndrome	2.36e-05	0.000121	CcSEcCtD
Metoprolol—Vomiting—Topiramate—epilepsy syndrome	2.27e-05	0.000117	CcSEcCtD
Metoprolol—Rash—Topiramate—epilepsy syndrome	2.25e-05	0.000116	CcSEcCtD
Metoprolol—Dermatitis—Topiramate—epilepsy syndrome	2.25e-05	0.000116	CcSEcCtD
Metoprolol—Headache—Topiramate—epilepsy syndrome	2.24e-05	0.000115	CcSEcCtD
Metoprolol—Nausea—Topiramate—epilepsy syndrome	2.12e-05	0.000109	CcSEcCtD
Metoprolol—CYP2D6—Metabolism—STXBP1—epilepsy syndrome	1.02e-05	0.000161	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	1.01e-05	0.000159	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1e-05	0.000159	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1e-05	0.000159	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCR3—epilepsy syndrome	9.98e-06	0.000158	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.97e-06	0.000158	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—CCR5—epilepsy syndrome	9.97e-06	0.000158	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CYP2D6—epilepsy syndrome	9.92e-06	0.000157	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—NT5E—epilepsy syndrome	9.92e-06	0.000157	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALAD—epilepsy syndrome	9.92e-06	0.000157	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADSL—epilepsy syndrome	9.86e-06	0.000156	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	9.83e-06	0.000155	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR3—epilepsy syndrome	9.76e-06	0.000154	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—HTR2A—epilepsy syndrome	9.75e-06	0.000154	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NPY—epilepsy syndrome	9.72e-06	0.000154	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ATP2A2—epilepsy syndrome	9.72e-06	0.000154	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GLUL—epilepsy syndrome	9.67e-06	0.000153	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADSL—epilepsy syndrome	9.63e-06	0.000152	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NPY—epilepsy syndrome	9.51e-06	0.00015	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ATP2A2—epilepsy syndrome	9.51e-06	0.00015	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	9.49e-06	0.00015	CbGpPWpGaD
Metoprolol—SLC22A2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	9.46e-06	0.00015	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AGT—epilepsy syndrome	9.46e-06	0.00015	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CACNA1A—epilepsy syndrome	9.46e-06	0.00015	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALDH7A1—epilepsy syndrome	9.46e-06	0.00015	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ADRA2A—epilepsy syndrome	9.45e-06	0.000149	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GLUL—epilepsy syndrome	9.44e-06	0.000149	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—BCHE—epilepsy syndrome	9.41e-06	0.000149	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL3—epilepsy syndrome	9.38e-06	0.000148	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CRH—epilepsy syndrome	9.38e-06	0.000148	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL2—epilepsy syndrome	9.38e-06	0.000148	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HSPB1—epilepsy syndrome	9.38e-06	0.000148	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—OXT—epilepsy syndrome	9.38e-06	0.000148	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	9.27e-06	0.000147	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ST3GAL3—epilepsy syndrome	9.26e-06	0.000146	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AGT—epilepsy syndrome	9.26e-06	0.000146	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCR5—epilepsy syndrome	9.25e-06	0.000146	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	9.21e-06	0.000146	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—OXT—epilepsy syndrome	9.18e-06	0.000145	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL2—epilepsy syndrome	9.18e-06	0.000145	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL3—epilepsy syndrome	9.18e-06	0.000145	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CRH—epilepsy syndrome	9.18e-06	0.000145	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HSPB1—epilepsy syndrome	9.18e-06	0.000145	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADSL—epilepsy syndrome	9.07e-06	0.000143	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—HTR2A—epilepsy syndrome	9.06e-06	0.000143	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCR5—epilepsy syndrome	9.05e-06	0.000143	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—SLC2A1—epilepsy syndrome	8.98e-06	0.000142	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	8.97e-06	0.000142	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GLUL—epilepsy syndrome	8.9e-06	0.000141	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	8.88e-06	0.00014	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PLCB1—epilepsy syndrome	8.88e-06	0.00014	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—HTR2A—epilepsy syndrome	8.86e-06	0.00014	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—TH—epilepsy syndrome	8.85e-06	0.00014	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.74e-06	0.000138	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CACNA1D—epilepsy syndrome	8.73e-06	0.000138	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TSC1—epilepsy syndrome	8.72e-06	0.000138	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PTK2B—epilepsy syndrome	8.72e-06	0.000138	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	8.67e-06	0.000137	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AQP1—epilepsy syndrome	8.62e-06	0.000136	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	8.61e-06	0.000136	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AGT—epilepsy syndrome	8.59e-06	0.000136	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—PRKCB—epilepsy syndrome	8.55e-06	0.000135	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	8.53e-06	0.000135	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PTK2B—epilepsy syndrome	8.53e-06	0.000135	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TSC1—epilepsy syndrome	8.53e-06	0.000135	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCR2—epilepsy syndrome	8.48e-06	0.000134	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SST—epilepsy syndrome	8.48e-06	0.000134	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NTRK2—epilepsy syndrome	8.48e-06	0.000134	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AQP1—epilepsy syndrome	8.41e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—DUSP6—epilepsy syndrome	8.41e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AGT—epilepsy syndrome	8.41e-06	0.000133	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADRA2A—epilepsy syndrome	8.3e-06	0.000131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR2—epilepsy syndrome	8.3e-06	0.000131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NTRK2—epilepsy syndrome	8.3e-06	0.000131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SST—epilepsy syndrome	8.3e-06	0.000131	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	8.28e-06	0.000131	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PLAT—epilepsy syndrome	8.27e-06	0.000131	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—DUSP6—epilepsy syndrome	8.23e-06	0.00013	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TXNRD1—epilepsy syndrome	8.17e-06	0.000129	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADRA2A—epilepsy syndrome	8.12e-06	0.000128	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PLAT—epilepsy syndrome	8.09e-06	0.000128	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—BDKRB2—epilepsy syndrome	7.98e-06	0.000126	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CXCL12—epilepsy syndrome	7.98e-06	0.000126	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—POMC—epilepsy syndrome	7.96e-06	0.000126	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—PRKCB—epilepsy syndrome	7.94e-06	0.000126	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AQP1—epilepsy syndrome	7.93e-06	0.000125	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—IL6ST—epilepsy syndrome	7.91e-06	0.000125	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—JUNB—epilepsy syndrome	7.83e-06	0.000124	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CNR1—epilepsy syndrome	7.83e-06	0.000124	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—BDKRB2—epilepsy syndrome	7.8e-06	0.000123	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CXCL12—epilepsy syndrome	7.8e-06	0.000123	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PLCB1—epilepsy syndrome	7.8e-06	0.000123	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	7.8e-06	0.000123	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	7.8e-06	0.000123	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—POMC—epilepsy syndrome	7.79e-06	0.000123	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—PRKCB—epilepsy syndrome	7.77e-06	0.000123	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—IL6ST—epilepsy syndrome	7.74e-06	0.000122	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	7.69e-06	0.000122	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CNR1—epilepsy syndrome	7.66e-06	0.000121	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—JUNB—epilepsy syndrome	7.66e-06	0.000121	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR7—epilepsy syndrome	7.64e-06	0.000121	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PLCB1—epilepsy syndrome	7.63e-06	0.000121	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CHRM3—epilepsy syndrome	7.61e-06	0.00012	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	7.61e-06	0.00012	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR7—epilepsy syndrome	7.47e-06	0.000118	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HBEGF—epilepsy syndrome	7.41e-06	0.000117	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—HMOX1—epilepsy syndrome	7.38e-06	0.000117	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—CAT—epilepsy syndrome	7.28e-06	0.000115	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT3—epilepsy syndrome	7.28e-06	0.000115	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	7.26e-06	0.000115	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HBEGF—epilepsy syndrome	7.25e-06	0.000115	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—POMC—epilepsy syndrome	7.23e-06	0.000114	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CHRM3—epilepsy syndrome	7.17e-06	0.000113	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—KCNJ11—epilepsy syndrome	7.17e-06	0.000113	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT3—epilepsy syndrome	7.12e-06	0.000113	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	7.11e-06	0.000112	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—ADAM10—epilepsy syndrome	7.11e-06	0.000112	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ABCB1—epilepsy syndrome	7.09e-06	0.000112	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—CCL2—epilepsy syndrome	7.08e-06	0.000112	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—POMC—epilepsy syndrome	7.07e-06	0.000112	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—ADAM10—epilepsy syndrome	6.95e-06	0.00011	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—CCL2—epilepsy syndrome	6.92e-06	0.000109	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—S100B—epilepsy syndrome	6.72e-06	0.000106	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SOCS3—epilepsy syndrome	6.66e-06	0.000105	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CDC42—epilepsy syndrome	6.64e-06	0.000105	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—GPX1—epilepsy syndrome	6.59e-06	0.000104	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—S100B—epilepsy syndrome	6.58e-06	0.000104	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SOCS3—epilepsy syndrome	6.51e-06	0.000103	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CDC42—epilepsy syndrome	6.5e-06	0.000103	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AVP—epilepsy syndrome	6.43e-06	0.000102	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	6.35e-06	0.0001	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AVP—epilepsy syndrome	6.29e-06	9.94e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ABCG2—epilepsy syndrome	6.2e-06	9.81e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	6.15e-06	9.73e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	6.11e-06	9.66e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HES1—epilepsy syndrome	6.08e-06	9.61e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	6.04e-06	9.56e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	6.01e-06	9.5e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HES1—epilepsy syndrome	5.95e-06	9.4e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FYN—epilepsy syndrome	5.91e-06	9.35e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—H2AFX—epilepsy syndrome	5.89e-06	9.31e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MEF2C—epilepsy syndrome	5.88e-06	9.3e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	5.84e-06	9.24e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FYN—epilepsy syndrome	5.78e-06	9.14e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AGT—epilepsy syndrome	5.78e-06	9.13e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—H2AFX—epilepsy syndrome	5.76e-06	9.11e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MEF2C—epilepsy syndrome	5.75e-06	9.1e-05	CbGpPWpGaD
Metoprolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	5.73e-06	9.05e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	5.7e-06	9.01e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—YWHAZ—epilepsy syndrome	5.68e-06	8.99e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	5.66e-06	8.95e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—APOE—epilepsy syndrome	5.66e-06	8.95e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—NGF—epilepsy syndrome	5.62e-06	8.89e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	5.57e-06	8.81e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—YWHAZ—epilepsy syndrome	5.56e-06	8.79e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	5.55e-06	8.78e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—NGF—epilepsy syndrome	5.5e-06	8.69e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCR5—epilepsy syndrome	5.47e-06	8.64e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	5.42e-06	8.57e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—HTR2A—epilepsy syndrome	5.35e-06	8.46e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCR5—epilepsy syndrome	5.35e-06	8.46e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	5.29e-06	8.36e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—BCHE—epilepsy syndrome	5.27e-06	8.33e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—HTR2A—epilepsy syndrome	5.23e-06	8.27e-05	CbGpPWpGaD
Metoprolol—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	5.17e-06	8.18e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	5.16e-06	8.16e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—BCHE—epilepsy syndrome	5.14e-06	8.13e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—TSC2—epilepsy syndrome	5.08e-06	8.04e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AGT—epilepsy syndrome	5.08e-06	8.03e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	5.02e-06	7.94e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—APOE—epilepsy syndrome	4.97e-06	7.86e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—TSC2—epilepsy syndrome	4.97e-06	7.86e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	4.97e-06	7.86e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AGT—epilepsy syndrome	4.97e-06	7.85e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—TH—epilepsy syndrome	4.95e-06	7.83e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	4.9e-06	7.75e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	4.87e-06	7.71e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—KDR—epilepsy syndrome	4.87e-06	7.7e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—APOE—epilepsy syndrome	4.86e-06	7.69e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	4.86e-06	7.69e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—POMC—epilepsy syndrome	4.86e-06	7.69e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PLCB1—epilepsy syndrome	4.85e-06	7.67e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—BCHE—epilepsy syndrome	4.84e-06	7.66e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—TH—epilepsy syndrome	4.83e-06	7.64e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—KDR—epilepsy syndrome	4.77e-06	7.54e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—PRKCB—epilepsy syndrome	4.69e-06	7.42e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—IL6ST—epilepsy syndrome	4.67e-06	7.39e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	4.62e-06	7.31e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—PRKCB—epilepsy syndrome	4.59e-06	7.25e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	4.57e-06	7.23e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—IL6ST—epilepsy syndrome	4.57e-06	7.23e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—TH—epilepsy syndrome	4.55e-06	7.2e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—ALB—epilepsy syndrome	4.43e-06	7.01e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—POMC—epilepsy syndrome	4.27e-06	6.76e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CCL2—epilepsy syndrome	4.18e-06	6.61e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—POMC—epilepsy syndrome	4.18e-06	6.61e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	4.13e-06	6.53e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CCL2—epilepsy syndrome	4.09e-06	6.47e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—CAT—epilepsy syndrome	4.08e-06	6.45e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—HMOX1—epilepsy syndrome	4.03e-06	6.38e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—CAT—epilepsy syndrome	3.98e-06	6.29e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	3.97e-06	6.27e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—PTGS2—epilepsy syndrome	3.88e-06	6.13e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	3.8e-06	6.01e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—FGF2—epilepsy syndrome	3.78e-06	5.97e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—CAT—epilepsy syndrome	3.75e-06	5.93e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—FGF2—epilepsy syndrome	3.7e-06	5.84e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—GPX1—epilepsy syndrome	3.69e-06	5.83e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	3.65e-06	5.77e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—GPX1—epilepsy syndrome	3.6e-06	5.69e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—RELA—epilepsy syndrome	3.51e-06	5.55e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MTOR—epilepsy syndrome	3.44e-06	5.44e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—RELA—epilepsy syndrome	3.43e-06	5.42e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—GPX1—epilepsy syndrome	3.39e-06	5.36e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MTOR—epilepsy syndrome	3.36e-06	5.32e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AGT—epilepsy syndrome	3.23e-06	5.11e-05	CbGpPWpGaD
Metoprolol—ADRB1—GPCR downstream signaling—AKT1—epilepsy syndrome	3.19e-06	5.05e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—APOE—epilepsy syndrome	3.17e-06	5.01e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—CASP3—epilepsy syndrome	3.16e-06	5e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AGT—epilepsy syndrome	3.16e-06	4.99e-05	CbGpPWpGaD
Metoprolol—ADRB2—GPCR downstream signaling—AKT1—epilepsy syndrome	3.12e-06	4.94e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—CASP3—epilepsy syndrome	3.09e-06	4.89e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—APOE—epilepsy syndrome	3.09e-06	4.89e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—JUN—epilepsy syndrome	3.07e-06	4.86e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—JUN—epilepsy syndrome	3.01e-06	4.75e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—MMP9—epilepsy syndrome	2.99e-06	4.73e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AGT—epilepsy syndrome	2.97e-06	4.7e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—MMP9—epilepsy syndrome	2.92e-06	4.62e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—APOE—epilepsy syndrome	2.91e-06	4.61e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling by GPCR—AKT1—epilepsy syndrome	2.9e-06	4.58e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling by GPCR—AKT1—epilepsy syndrome	2.84e-06	4.48e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—SRC—epilepsy syndrome	2.76e-06	4.36e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—POMC—epilepsy syndrome	2.72e-06	4.3e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—SRC—epilepsy syndrome	2.7e-06	4.26e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—VEGFA—epilepsy syndrome	2.68e-06	4.24e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—POMC—epilepsy syndrome	2.66e-06	4.2e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—VEGFA—epilepsy syndrome	2.63e-06	4.15e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—POMC—epilepsy syndrome	2.5e-06	3.96e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—ALB—epilepsy syndrome	2.48e-06	3.92e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—ALB—epilepsy syndrome	2.42e-06	3.83e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—ALB—epilepsy syndrome	2.28e-06	3.61e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	2.17e-06	3.43e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.12e-06	3.35e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	2e-06	3.16e-05	CbGpPWpGaD
Metoprolol—SLC22A2—Metabolism—AKT1—epilepsy syndrome	1.95e-06	3.08e-05	CbGpPWpGaD
Metoprolol—ADRB1—Signaling Pathways—AKT1—epilepsy syndrome	1.71e-06	2.71e-05	CbGpPWpGaD
Metoprolol—ADRB2—Signaling Pathways—AKT1—epilepsy syndrome	1.68e-06	2.65e-05	CbGpPWpGaD
Metoprolol—CYP2C19—Metabolism—AKT1—epilepsy syndrome	1.09e-06	1.73e-05	CbGpPWpGaD
Metoprolol—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.06e-06	1.68e-05	CbGpPWpGaD
Metoprolol—CYP2D6—Metabolism—AKT1—epilepsy syndrome	1e-06	1.59e-05	CbGpPWpGaD
